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Background/aim: Urticaria is a vascular skin reaction characterized with papules and plaques. Neopterin is accepted as an immunologic
marker and an indicator of activation of the immune system. Homocysteine and asymmetric dimethylarginine (ADMA) are the markers
of increased vascular resistance. Alteration in vascular resistance has a role in the pathogenesis of urticaria. We aimed to investigate
whether there is a relationship between urticaria and neopterin, homocysteine, or ADMA.
Materials and methods: The study is designed as a prospective descriptive study and patients with a diagnosis of urticaria in the
emergency department were included in the study. Demographic data and characteristics of the disease were recorded. Neopterin,
homocysteine, and ADMA levels were measured both during and after urticaria attacks. All data were statistically analyzed.
Results: The differences between neopterin levels measured during and after urticaria attacks were statistically significant (P < 0.001). The
differences between homocysteine and ADMA levels measured during and after urticaria attacks were not statistically significant (P > 0.05).
Conclusion: Our results indicate that neopterin levels in patients with urticaria attacks are increased and the level of neopterin is
also a useful parameter in acute urticaria. Further studies should clarify whether homocysteine levels contribute to diagnosis of acute
urticaria. However, no relation was found between ADMA and urticaria.
Key words: Acute urticaria, neopterin, homocysteine, ADMA

1. Introduction
Acute allergic syndromes are common problems in
primary care and in emergency departments (1). The
life-time prevalence for any subtype of urticaria is
approximately 20% (2). These are a heterogeneous
group of disorders with a large variety of underlying
causes. One of them is acute urticaria (AU) (3).
Urticaria involves common and histaminergic reactional
lesions localized to the superficial dermis of the skin,
generally resolved in 24 h (4). These lesions are usually
intensely pruritic, erythematous, well circumscribed,
and evanescent. Primary care management in AU is
symptomatic treatment regardless of the underlying
* Correspondence: drskemal@gata.edu.tr

cause. Symptomatic treatments include antihistamines,
corticosteroids, or adrenaline (5).
Neopterin is synthesized from guanosine triphosphate
and produced preferably by macrophages and monocytes
(6). Elevated neopterin concentrations in serum or urine
are associated with infection diseases, autoimmune
diseases, inflammatory diseases, and organ transplantation
rejection (7,8). In addition, it correlates with disease stage
and predicts a poor prognosis (8,9). Stimulating the
immune system, neopterin is accepted as an immunologic
marker and an indicator of activation of the immune
system (10). Neopterin may be a useful marker in acute
allergic syndromes such as AU.
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Asymmetric dimethylarginine (ADMA) is produced
by methylation of arginine residues of the intracellular
proteins (11,12). ADMA is an endogenous nitric oxide
synthase (NOS) inhibitor that contributes to cardiovascular
disease pathogenesis related to endothelial dysfunctions
such as atherosclerosis, diabetes mellitus, and chronic
renal disease (13,14). It has been presumed that ADMA
has an important role in the regulation of the L-arginine/
nitric oxide (NO) pathway (15,16). NO has a role in
pulmonary physiological regulation of bronchodilation,
airway responsiveness, and airway inflammation (16,17).
Klein et al. reported that elevated ADMA concentration
results in the inhibition of NOS that leads to smooth
muscle constriction in the airway (17).
Homocysteine (Hcy) is a sulfur-containing
essential amino acid. High plasma Hcy levels have an
important role in the pathogenesis of various diseases,
especially in the cardiovascular system (18,19). As a
prooxidant, homocysteine was found to increase reactive
oxygen species, endothelin-1, ADMA, and various
adhesion molecules such as ox-LDL and to reduce
tetrahydrobiopterin bioavailability, leading to decreased
bioavailability of eNOS and endothelial dysfunction (20).
In some studies, it was suggested that Hcy may play a role
in increased oxidative stress in the damage to vascular
endothelial cells (21,22). It was also hypothesized that
Hcy-lowering independent mechanisms are linked to a
reduction of oxidative stress (20).
In a recent study it was demonstrated that serum
neopterin levels are increased in AU as compared with
chronic urticaria (23). Homocysteine and ADMA are
markers of increased vascular resistance. Alteration
in vascular resistance has a role in the pathogenesis
of urticaria (24,25). Although serum neopterin, Hcy,
and ADMA levels are associated with various clinical
syndromes demonstrating similar pathogenesis as AU in
the literature, a study including AU in patients with these
three parameters analyzed together could not be found. To
the best of our knowledge, this is the first study aimed at
investigating the associations between urticaria and serum
neopterin, plasma total Hcy (tHcy), and ADMA levels.
2. Materials and methods
2.1. Patients
Seventy-seven consecutively admitted patients presenting
with AU in the Department of Emergency Medicine,
Gülhane Military Medical Academy, Ankara, Turkey,
were included in this study. Oral and written consent was
obtained from all patients, and authorization was given
by the ethics committee of Gülhane Military Medical
Academy, Ankara, Turkey (1491-82-11/1539-156405.24.2011).
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By completing a questionnaire, relevant background
information was provided by these volunteers and
included medication, presence of allergy and its types,
history of atopy, and hereditary and other diseases. History,
initial symptoms, physical findings, and treatments were
noted. The number and the extent of involvement with
urticaria were assessed and recorded. Each urticaria case
was evaluated with the urticaria activity score (UAS) as
previously described (2). Briefly, the urticarial lesions
and pruritus were scored on a scale of 0 to 3 (normal to
severe) for a total score of 0–6. All patients were treated
with antihistamines and steroids during attack.
2.2. Blood sampling
Blood samples were obtained twice from all the patients:
first during the attack of urticaria before any treatment
and secondly 15 days after treatment. The blood samples
were centrifuged at 2000 rpm for 10 minutes and stored at
–80 °C until being analyzed. Because neopterin is slightly
sensitive to direct sunlight, samples were protected from
light during transport and storage by enveloping the
samples in aluminum foil.
2.3. Measurement of ADMA
Measurement of ADMA was accomplished by highperformance liquid chromatography (HPLC) using the
method described by Cayci et al. (26). In brief, to 1 mL
of serum, 20 mg of 5-sulfosalicylic acid was added, and
the mixture was left in an ice bath for 10 min. Samples
were centrifuged at 2000 × g for 10 min and then 10 µL
of supernatant was filtered through a 0.2-µm filter. It was
mixed with 100 µL of derivatization reagent (consisting
of o-phthaldialdehyde, methanol, borate buffer, and
2-mercaptoethanol) and then injected into the HPLC
system. ADMA separation was performed using a 150
× 4 mm C18 Nova-Pak column with 5-µm particle size
(Waters, Millipore Corp., Milford, MA, USA), and 50
mmol/L sodium acetate buffer (pH 6.8), methanol, and
tetrahydrofuran were used as mobile phases (A, 82:17:1; B,
22:77:1; % v). Flow rate was 1.0 mL/min. The wavelengths
of the fluorescence detector were set at 338 nm for
excitation and 425 nm for emission. The variability of the
method was less than 7%, and the detection limit of the
assay was 0.1 µm.
2.4. Measurement of serum neopterin
Serum neopterin levels were measured with an HPLC
device (Agilent Technologies 1200 Series System, Santa
Clara, CA, USA), using the method defined by Gul et
al. (27). Briefly, 100 µL of 2 M trichloroacetic acid was
added to 500 µL of serum for protein precipitation. Then
samples were centrifuged at 4 °C and 2000 × g for 10 min,
and then 100 µL of supernatant was filtered and injected
into the HPLC system. ADMA separation was performed
using a 250 × 4.6 mm C18 Allsphere ODS-2 analytical
column with 5-µm particle size (Alltech, Deerfield, IL,
USA) and an Allsphere ODS-2 guard column (Alltech),
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and 0.015 M phosphate buffer (pH 6.4) was used as the
mobile phase (isocratic elution). Flow rate was 0.8 mL/
min. The wavelengths of the fluorescence detector were set
at 353 nm for excitation and 438 nm for emission. Serum
neopterin levels were expressed as nmol/L. The intraassay
and interassay coefficients of variations (CV %) were
0.85% and 1.07%, respectively.
2.5. Homocysteine measurement
Plasma tHcy concentrations were measured using a fully
automated HPLC system with a fluorescence detector
(Shimadzu RF-10AxL) and Hcy kits (ImmuChrom GmbH,
Heppenheim, Germany) using the method described by
Akgül et al. (28). The intraassay and interassay coefficients
of variations (CV %) were 1.83% and 2.94%, respectively.
2.6. Statistical analysis
All statistical analyses were performed by using SPSS
15.0 (SPSS Inc., Chicago, IL, USA). Distributions were
evaluated using the one-sample Kolmogorov–Smirnov
test. Wilcoxon tests and Mann–Whitney U-tests were
used for testing differences between groups. The results
were expressed as mean ± standard deviation, median
(minimum–maximum), and number (frequency). The
Spearman rho correlation test was used to indicate
relationships between variables. P < 0.05 was considered
statistically significant.
3. Results
Of 77 consecutively admitted patients presenting with AU
in the Department of Emergency Medicine, 48 (62.3%) and
29 (37.7%) were women and men, respectively. The mean
age of patients was 42 ± 15 (range: 19–79) years. Fortynine of the patients had symptoms for no longer than 24
h before being admitted. The rest of patients (n = 28) had
symptoms for more than 24 h. Hypertension, diabetes
mellitus, acute coronary syndrome, and chronic urticaria
were noted in 12, 8, 2, and 1 patients, respectively. There
was a history of atopy in 24 patients. Food allergy and
drug allergy were noted in 5 and 9 patients, respectively.
In the patients’ history, there was cold urticaria (n = 1),
contact urticaria (n = 1), and demographic urticaria (n

= 1). In addition, there were no urticaria types including
heat, cholinergic, solar, aquagenic, or exercise-induced.
According to UAS evaluation, 15, 15, 15, 10, 12, and 10
of the patients had 6, 5, 4, 3, 2, and 1 points, respectively.
The concentrations of plasma tHcy and ADMA and
of serum neopterin are shown in the Table. There was no
difference in plasma tHcy or ADMA concentrations in
any patients during and after the attacks of urticaria (P >
0.05 for both). Serum neopterin levels during attacks were
significantly higher than those after attacks (P < 0.001).
There was a statistically significant correlation between
plasma tHcy levels after attack and serum neopterin
levels both during and after attack (r = 0.424, P = 0.009
and r = 0.523, P = 0.001, respectively). Moreover, there
was a statistically significant correlation between serum
neopterin levels during and after attack (r = 0.483, P
= 0.002) (Figure). However, there was no correlation
among UAS, serum neopterin, plasma tHcy, and ADMA
concentrations during and after attack.
4. Discussion
In this study, we examined the associations between
urticaria and serum neopterin, plasma tHcy, and ADMA
levels. To our best knowledge, this is the first study to do so.
Many of the patients described in our study had
increased UAS. No patients had loss of consciousness or
required cardiopulmonary resuscitation or intubation.
All patients had elevations of serum neopterin, plasma
ADMA, and tHcy during the urticaria attack. There was
no statistically significant difference in plasma tHcy or
ADMA concentrations of any patients during and after
attacks of urticaria. These findings suggest that elevated
levels of plasma tHcy and ADMA do not appear to
initiate the attack of AU, and increased production of
these molecules may potentiate AU. In addition, it has
been shown that plasma tHcy may increase in response
to immune activation and cell proliferation during type 1
immune response (23). Nevertheless, plasma tHcy was not
associated with the attack of AU in our study, suggesting
that plasma tHcy may not be the causal factor in AU.

Table. Biochemical parameters.
Parameters

During attack

After attack

P*

Plasma total homocysteine (µmol/L)

10.40 ± 3.88

9.66 ± 1.62

0.330

Serum neopterin (nmol/L)

15.06 ± 5.18

9.27 ± 1.61

<0.001

Plasma ADMA (µmol/L)

0.69 ± 0.43

0.55 ± 0.15

0.090

ADMA: Asymmetric dimethylarginine.
All data are expressed as mean ± standard deviation.
*Mann–Whitney U-test.
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Figure. The correlation of serum neopterin concentrations
during urticarial attack and after attack.

During the attack of urticaria serum neopterin levels were
statistically higher than after the attack. This predominance
of neopterin elevations compared with plasma ADMA and
tHcy elevations was observed in all patients.
Ciprandi et al. demonstrated that serum neopterin
levels are increased in AU compared with chronic urticaria
(10). In our study, we found that serum neopterin levels
were increased during the attack of urticaria as compared
to after the attack. Therefore, our results were similar with
the results of the study performed by Ciprandi et al. (10).
In addition, they did not find any correlation between
serum neopterin level and severity of disease. In our study,
we also showed no correlation between serum neopterin
level and severity of urticaria. High serum neopterin levels
might show possible infectious diseases and immune
system disorders. However, there were no infectious or
immune system diseases in our study population. The
observed elevation in serum neopterin levels may suggest
immune activation and increased monocyte/macrophage
activities in AU. Neopterin stimulates the immune system

(29). In a recent study, Murr et al. showed that increased
neopterin production is associated with inflammation
and immune activation (30). As neopterin is a marker of
activated monocytes/macrophages, our data suggest that
activated monocytes/macrophages may play a role in the
pathophysiology of AU. Monocytes and macrophages may
be also the primary effectors in the pathogenesis of AU. Some
autoimmune and inflammatory diseases such as systemic
lupus erythematosus, psoriasis, and dermatomyositis have
generally elevated neopterin concentrations (31,32). In
a study performed by Reinhold et al., it was shown that
the patients with severe atopic dermatitis had elevated
serum neopterin levels (33). However, in another study,
there was no difference between serum neopterin levels
of the patients with chronic urticaria and healthy control
subjects (10). Increased serum neopterin levels in AU
appear first of all to point toward high activity of the
urticarial inflammation.
Our study may have several limitations. We think that
there is a lack of measurements of systemic inflammation
markers such as IL-6 and CRP during urticarial attacks.
Our study group was relatively small in sample size.
Another limitation of our study might be the lack of
follow-up of patients with AU.
In conclusion, we have shown that serum neopterin
concentrations are associated with the attack of urticaria.
Our data suggest that neopterin is a marker of activated
monocytes/macrophages and activated monocytes/
macrophages may play a role in the pathophysiology of
AU. These preliminary results demonstrate that serum
neopterin levels may be used as a biomarker of immune
activation in AU. Further studies should be performed to
confirm these findings.
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